Overview

Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and efficacy of iAPA-DC/CTL combined gemcitabine therapy on advanced pancreatic cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Changhai Hospital
Collaborator:
ImmunoGene Biotechology Co.,Ltd
Treatments:
Gemcitabine